Description: Creo Medical Group plc is a United Kingdom-based medical device company. The Company focuses on the field of surgical endoscopy. The Company focuses on the development and commercialization of minimally invasive surgical devices, initially in the area of gastrointestinal (GI) surgery and lung cancer. The Company has developed CROMA, which is an electrosurgical platform that can deliver microwave and bipolar radiofrequency through a single accessory port. The Company's surgical system CROMA combines bipolar radiofrequency for localized cutting and microwave energy for controlled coagulation, which provides physicians with simplified and controlled surgical solutions. The Company's pipeline portfolio of instruments is targeted at three therapeutic endoscopic specialties: lower GI; lung/bronchoscopy and upper GI.
Home Page: creomedical.com
CREO Technical Analysis
Creo House
Chepstow,
NP16 5UH
United Kingdom
Phone:
44 1291 606005
Officers
| Name | Title |
|---|---|
| Mr. Craig Jonathan Gulliford | CEO & Exec. Director |
| Prof. Christopher Paul Hancock | Founder, CTO & Exec. Director |
| Mr. Richard John Rees ACA | CFO, Company Sec. & Exec. Director |
| Mr. David Gerard Woods | Chief Commercial Officer & Exec. Director |
| Mr. Phil Hales | Sales & Marketing Director |
Exchange: LSE
Country: UK : United Kingdom
Currency: Pence sterling (p)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0696 |
| Price-to-Sales TTM: | 2.4845 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 316 |